2021 Fall Senior Executive Conference
Laguna Beach, California
Details Members Register Here >
Members — Register Here!
The Fall Senior Executive Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on the future of immunology, digital and the implications for health (assessing the use of artificial intelligence and machine learning in healthcare, blockchain technology and IoT), and how the ‘omics technologies are evolving (genomics, proteomics and metabolomics). We include a global economic and financial outlook to complement each topical program.
The topic for this event will be proteomics; the newest developments in this space, how companies are capitalizing on these opportunities, and the implications for ALDA member companies. Attendees will experience the top-tier sessions and networking you have come to expect at an ALDA event.
The Proteomics Evolution: What’s New & What’s Next
Sunday, October 3
Opening Reception & Dinner
Former FBI hostage negotiator
Co-author of the book “Never Split the Difference”
Monday, October 4
9:00 AM to 12:00 PM
Next-gen Proteomics: Outlook and Opportunities in a Massive Market
Presented by Puneet Souda
Senior Research Analyst at SVB Leerink covering Life Science Tools and Diagnostics
The Latest in Proteomics Applications & Forward-looking Research
Presented by Jennifer van Eyk, PhD, Cedars Sinai
Director, Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences — Erika J. Glazer Chair in Women’s Heart Health, Director, Basic Science Research in the Women’s Heart Center; Professor, Medicine and Professor, Biomedical Sciences
12:00 Noon to 1:30 PM Luncheon
1:30 PM to 4:15 PM
Proteomics 3.0, machine learning, and the singularity
Presented by John Yates III, PhD, Scripps Research
Professor, Department of Molecular Medicine, California Campus; Editor-in-Chief: Journal of Proteome Research
CEO Roundtable from Dynamic Proteomics Companies
- Omid Farokhzad, Chief Executive Officer and Chairman, Seer
- Jon Heimer, CEO, Olink
- Sujal Patel, Founder and Chief Executive Officer, Nautilus Biotechnology
- Roy Smythe, CEO, SomaLogic
- Alex Vadas, Managing Director & Partner, Biopharmaceuticals & Life Sciences, L.E.K. Consulting, Moderator
Tuesday, October 5
8:00 to 9:30 AM
Closing Keynote Speaker: A Conversation with Michael Lewis
Presented by Michael Lewis, best-selling author of modern classics including “Moneyball”, “The Blind Side”, “The Big Short”, “Liar’s Poker” and, most recently, “The Premonition: A Pandemic Story”
Contact Carol Starke for registration details (firstname.lastname@example.org). Attendance at this and other ALDA events is for ALDA members. Contact Kerrie Peterson (email@example.com) for membership information and how to join ALDA.
**Hotel reservation information is included in your conference confirmation once you register.
**The health and safety of our members and attendees has been and will continue to be our top priority. We will continue to monitor and work with The Montage Resort to make sure protocols are in place at the hotel to execute a safe event, as well as monitor and make you aware of any travel requirements needed to attend the event in-person, especially for those traveling from Europe or other international locations.
REGISTRATION CANCELLATION POLICY:
You can cancel your registration until Wednesday, September 22 and receive a refund. If you must cancel, please remember that you are also responsible for canceling your hotel reservations. We will work on a case-by-case basis after September 22 if you must cancel due to Covid restrictions.
HEALTH & SAFETY PROTOCOLS:
First, all attendees must be vaccinated.
Second, all attendees must pass an onsite Rapid PCR test to gain entrance to the event.
By attending the conference, you are agreeing to these guidelines. We recognize these precautions are not 100% fail-safe, but we are doing everything we can to provide a safe and engaging environment while respecting the individual accountability and professionalism of our attendees. These measures will ensure a comfort level that will allow attendees—if they so choose—to participate in the conference without wearing a mask and without implementing strict distancing guidelines. We feel this enables us to deliver a meeting on par with the high standards ALDA has set for our events.
HOTEL INFORMATION: Details on how to reserve a room for the conference are included with your registration confirmation.
ALDA 2021 Virtual Service & Support Executives Conference
ALDA 2021 Virtual Service & Support Executive Conference
11:00 AM – 1:00 PM Eastern
Join your peers and colleagues as ALDA’s Service & Support Executive Conference continues to go virtual. Based on feedback from past attendees, we will be tackling top-of-mind issues for navigating the new normal and building for the future of service.
Time, date and more information coming soon!
Breakfast Meeting at AMP
We typically hold a breakfast at this trade show. The breakfast presents a great opportunity to meet and network with other senior executives from our members and invited guests attending the AMP Annual Meeting and Show.
In addition to presenting a great opportunity to meet and network with other ALDA member executives and a few key membership prospects attending AMP, we also invite a guest speaker.
Regional Senior Executives Dinner
Directed to senior executives, especially those in the Boston and Northeast area, our regional dinners present a great opportunity to connect with and stay in touch with other companies and top executives in an informal environment outside of ALDA’s semi-annual meetings.
We are pleased that Hanno and Judith Steen, Associate Professors at Harvard Medical School, will join us to share the latest from their research and the work of their lab, The Steen Laboratory.
The lab is run jointly by Judith A. J. Steen, an Associate Professor of Neurobiology at Harvard Medical School, a member of the Harvard Stem Cell Institute and the Director of the Neuroproteomics Laboratory in the F. M. Kirby Neuroscience Center at Boston Children’s Hospital. and Hanno Steen, an Associate Professor of Pathology at Harvard Medical School, appointed in the Pathology Department of Boston Children’s Hospital and the Precision Vaccines Program. This presentation will complement our upcoming west coast conference focused on “The Proteomics Evolution: What’s New & What’s Next.”
Hanno and Judith will share information regarding the development and application of novel and improved mass spectrometric and proteomic methods for the analysis of human disease-relevant tissues and body fluids. In addition, they are also developing bioinformatic pipelines to increase the information content in proteomic data, among other topics relevant to the ALDA audience.
The dinners also present an opportunity to introduce members of your executive team who may not regularly attend our senior executive meetings to the ALDA network.
2022 Spring Senior Executives Conference
The Spring Senior Executives Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on pandemics and infectious diseases, single cell biology, and synthetic biology. We include a global economic and financial outlook to complement each topical program.
Welcome New Members!
We look forward to welcoming you in person, but until then we have several new member video introductions.
Our Fall Senior Executive Conference, taking place October 3-5, is in-person!
Please click HERE for information related to the complexities of travel to the U.S. from European countries for our Fall Conference
D&I Benchmarking Summary & Next Steps Webinar on September 20
A message from Mike Copps--ALDA's Year in Review
Meet Our Members
Membership is open to companies with a life science, analytical, and diagnostics technology business.
These companies include manufacturers and suppliers of:
- Analytical Instruments, Reagents, and Consumables
- Lab Automation Tools
- Life Science Instrumentation, Reagents, and Consumables
- Software and Informatics – pure play sales force software
- Clinical Invitro & Advanced Diagnostics
ALDA meetings, market data, and surveys are tailored specifically for CEOs, presidents, and senior executives of member companies.
Dues are based on the member company’s global analytical, life science, and diagnostics business revenues for the most recent business year. Companies that are the U.S. or North American division of an overseas corporation can choose to pay dues based on their global revenues or their North American business revenues.
In addition to the annual dues members pay registration fees for attendees at some meetings. For most member companies that is estimated to average between $5-7K USD per year.
“Diagnostics” business refers to revenues from: molecular diagnostics; companion diagnostics; and emerging and next generation diagnostic technologies such as cellular diagnostics.
|Annual Revenues (in US Dollars)||Annual Dues|
|Under $10 million||$2,625|
|Over $750 million||$33,000|
ALDA meetings, market data and surveys are directed to CEOs, presidents, and members of their senior executive teams. Most members agree that the most important membership benefit is the opportunity to regularly meet, have dialog, and develop strategic business relationships with others.
We offer the opportunity to connect the industry and its leaders and glad assist in making introductions between one member company to another.
Throughout 2020 and the early part of 2021 ALDA held virtual conferences with the fall 2020 conference focused on artificial intelligence and our spring conference focused on pandemics and infectious disease.
Senior Executives Meetings
Semi-annual meetings focus on timely topics and feature world-class speakers who offer strategic insights into trends, emerging technologies, and new markets. Leading business-school academics and industry consultants provide keynote presentations.
The Spring Meeting is typically held in Boston on the first Sunday-Tuesday in May and our Fall Conference is held on the West Coast on the first Sunday-Tuesday in October.
Recent ALDA Semi-annual Meeting Topics:
- 2021 Spring: Pandemics & Infectious Disease
- 2020 Fall: Artificial Intelligence
- 2020 Spring: ALDA Senior Executive Education: Scott Gottlieb and McKinsey & Company
- 2019 Fall: Immunology
- 2019 Spring: Single Cell Biology
- 2018 Fall: Digital and the Transformation of Healthcare
- 2018 Spring: Synthetic Biology
- Annual Meeting for Senior Marketing & Sales Executives
- Annual Meeting for Senior Customer Service & Support Executives
- 2 Regional Senior Executive Dinners – one in Boston & one in the San Francisco Bay area
- Trade Show Breakfast Meetings which include AACC, AMP, Analytica, ECCMID, and SLAS
Virtual Working Groups for HR and Operations Executives called Collaboratives – these are designed to bring industry experts and your leadership teams together to share best practices used to help manage the COVID crisis. Work from Home, Back to Work and most recently, how member companies are handling the vaccination process for employees have been topics covered with this group.
ALDA meetings offer opportunities to make valuable contacts and engage in dialogue. Increase your company’s visibility and gain valuable industry connections for business partnerships, OEM and sales opportunities, strategic investment, and mergers and acquisitions. In addition, trade show events and annual dinner meetings on both coasts make it easy to network with other industry executives, customers, and international organizations.
“ALDA brings together some of the brightest and most talented minds from both the life science and diagnostics space – it is a forum where we can truly interact and network with one and other in a way that no other industry association has enabled.”
Kamni Vijayena, Vice President and General Manager, Genomics Bio-Techne
ALDA sponsors four market data reports.
1. The Industry Market Assessment Report is published quarterly and sent to all members of ALDA. The cost is included in your annual dues. The report contains a high level overview of the global market and 15 product/market segments, and is designed to complement your internal market research. Official and alternate representatives will automatically receive this report.
The following three reports are available only to participants:
2. The Global Lab Instruments Bookings Report tracks global bookings (orders) on a quarterly basis for about a dozen laboratory analytical instrument systems including LC, GC, LC-MS, GC-MS, UV/Vis, AA, FTIR and ICP products. ALDA jointly sponsors this report with instrument associations in Japan and Europe.
3. The Microplate Reader Sales Report tracks global sales on a semi-annual basis for three categories of microplate reader products: single-mode microplate readers, multi-mode microplate readers, and washers.
4. The Bio-Research Reagents Market Report tracks sales on a semi-annual basis for several categories of life science reagents and consumables. The report is offered on a subscription basis through the ABA Audits firm in the UK, and ALDA subsidizes a portion of the participation fee for our members.
ALDA members are invited to participate in the Pearl Meyer CHiPS One World Total Compensation Survey at the special fee of $995 USD. (2020)
The CHiPs One World survey reports positions based on salary, short-term and long-term incentives, total cash/target and direct compensation, and global merit increases.
Participants receive an all-participants report, a custom peer group report and an ALDA-only report, along with a full year of 24/7 access to CHiPs online with free on-demand features.
The CHiPS One World also offers one-to-one account support through their dedicated team of account managers. This customized approach ALDA members go beyond the data to understand how the survey results apply to their organization and its unique compensation needs.
D&I Benchmark Survey
ALDA members were invited to participate in our first D&I survey which Pearl Meyers conducted our us. More than 45 member companies submitting information and have access to the final results. Initial feedback is that this survey is highly detailed and insightful for those participating companies. ALDA expects this to help us develop strategic programs moving forward.
How to Join
If you are interested in learning more about the association or if you are ready to join please contact Kerrie Peterson our Director of Membership at firstname.lastname@example.org.
- Pall Corporation, a Danaher Company
- Parker Hannifin
- Peak Scientific Instruments Ltd.
- PerkinElmer Inc.
- Persistent Systems
- Personal Genome Diagnostics
- Phase Genomics, Inc.
- PHC Holdings Corporation
- Planet Innovation
- Precision NanoSystems, Inc.
- PreOmics GmbH
- Presco Engineering
- Promega Corporation
- Protein Dynamic Solutions LLC
- Protein Metrics Inc.
- Purigen Biosystems, Inc.
ALDA (Analytical, Life Science & Diagnostics Association) is a non-profit industry trade association for global companies that develop and market products and services used in life science research, drug discovery, QA/QC and food testing, and clinical and molecular diagnostics.
ALDA’s meetings, data and programs are directed to C-suite executives, presidents and senior executives of our member companies to help them to develop business strategies to grow their business.
Member companies range from the industry’s largest suppliers to medium-size and small pre-product companies. Together, our analytical and life science members account for more than 70 percent of the industry’s global revenues. Our diagnostics members manufacture and supply molecular diagnostics, companion diagnostics, and emerging and next-generation diagnostic technologies.
ALDA is headquartered in Alexandria, Virginia, USA.
ALDA members participate in the $70 billion life science, analytical & diagnostics tools market. Participating companies supply instrumentation, reagents, consumables, assays, and related services for life science research, drug discovery, food safety, QA & QC testing along with clinical and diagnostics testing.
Having deep insights in the life sciences enables ALDA members to connect life science research to clinical diagnostics and brings diagnostic solutions faster to market. This enables better diagnostics and helps more patients throughout the world.
Board of Directors
President and Chief Executive Officer
Chief Executive Officer
All ALDA meetings feature strategic presentations and are designed to facilitate networking opportunities. Customers and users often attend these meetings and present insights about their evolving needs for our industry’s products and services.
ALDA offers a variety of meetings:
- Semi-annual meetings for CEOs, presidents, and senior executives. These meetings focus on timely topics and feature world-class speakers who offer strategic insights into trends, emerging technologies, and new markets. Leading business-school academics and industry consultants provide keynote presentations. The Spring Meeting is typically held in Boston on the first Sunday-Tuesday in May and our Fall Conference is held on the West Coast on the first Sunday-Tuesday in October.
Throughout 2020 and the early part of 2021 ALDA held virtual conferences with the fall 2020 conference focused on artificial intelligence and our spring conference focused on pandemics and infectious disease.
- An annual meeting for senior marketing and sales executives, and senior service and support executives
- Two regional senior executive dinners – one in Boston & one in the San Francisco Bay area
- Trade show breakfast meetings including AACC, AMP, Analytica, ECCMID, and SLASVirtual Working Groups for HR and Operations Executives called Collaboratives – these are designed to bring industry experts and your leadership teams together to share best practices used to help manage the COVID crisis. Work from Home, Back to Work and most recently, how member companies are handling the vaccination process for employees have been topics covered with this group.”
“While the meeting content focuses on learning more about the scientific trends (which) help us as leaders to stay current, the meetings help with networking and understanding the various companies and actors in the industry.”
Rainer Blair, President & Chief Executive Officer, Danaher Corporation
Market Data & Compensation Survey
When you join ALDA, you connect with comprehensive, current insight into the industry. ALDA produces four market data reports.
The Industry Market Assessment Report is delivered quarterly to all members, whereas specific market reports are provided to participating companies only. You will find more details on each report below.
Members use our reports to benchmark operations against industry data and averages and:
- Improve efficiency and performance
- Broaden their perspective on global users and markets
- Identify and track emerging trends
Industry Market Assessment Report
This quarterly report is designed specifically for senior executives and is delivered to all ALDA member companies.
It contains a high-level overview of the global market and 15 product sectors. Among the 15 product sectors are life science instruments and reagents, cell analysis, liquid chromatography, and mass spectroscopy and lab automation.
Global Lab Instrumentation Bookings Report
This is a quarterly report that covers bookings for multiple analytical product sectors. Bookings are divided into North America, Europe, Japan, China, India, Latin America, and rest of world (ROW).
Member companies must provide data in order to receive this report.
Sectors covered include:
- Total Laboratory Analytical Business
- Gas Chromatographs (GC)
- Gas Chromatograph-Mass Spectrometers (GC-MS)
- Liquid Chromatographs (LC)
- Liquid Chromatograph-Mass Spectrometers (LC-MS)
- Ultra Violet/Visible/Near Infrared Spectrophotometers (UV/Vis/NIR)
- Atomic Absorption Spectrometers (AA)
- Fourier Transform Infrared Instruments (FTIR)
- Total Organic Carbon Analyzers (TOC Analyzers)
- Fluorescence Spectrophotometers (FS)
- Inductively Coupled Plasma Systems (ICP)
- Inductively Coupled Plasma–Mass Spectrometers (ICP-MS)
Bio-Research Reagents Market Report
This semi-annual report is produced for ALDA by ABA Audits Ltd. of the United Kingdom and member companies must provide data in order to receive this report.
It covers sales of products in 14 groups, including:
- Cell Research
- General Biochemicals
- Specialty Research
- Amplification & PCR
- Real Time
- Labeling & Detection
- Protein, Enzymes & Peptides
- Substrates & Receptors
- Cell Research Kits & Specialty Kits
- Assay Kits
Microplate Reader Report
This report is issued semi-annually and member companies must provide data in order to receive this report.
It covers three product segments in a spreadsheet format and contains data for the current period and past historical periods.
Product groups addressed include:
- Single-mode: combining scintillation, fluorescence, and luminescence
ALDA members are invited to participate in the Pearl Meyer CHiPS One World Total Compensation Survey at the special fee of $995 USD (2019).
The CHiPs One World survey will provide your company with accurate and comprehensive information at an affordable rate. All elements of the employee pay package are collected and reported, providing your company with the information needed to analyze your competitive position and compensation mix from a total compensation perspective.
Among the data to be reported for each position are base salary, short-term and long-term incentives, total cash/target and direct compensation, and global merit increases.
Participants will receive an all-participants report, a custom peer group report and an ALDA-only report, along with a full year of 24/7 access to CHiPs online with free on-demand features.
The CHiPS One World also offers one-to-one account support through their dedicated team of account managers. This customized approach will help you to go beyond the data to understand how the survey results apply to your organization and its unique compensation needs.
Even if your company participates in other compensation surveys, the ALDA-sponsored survey will provide valuable information that will allow you to “test” and compare the results of other surveys.
Participants’ data is typically collected during the Spring with final submissions due in early May and a July 1 publication of the final report.
This survey covers:
- Base salaries
- Incentive eligibility and pay
- Bonus compensation for each position
- Mix of base and incentive pay
- Compensation practices
- Salary administration
- Professional and managerial total compensation
- Data reported on a country-by-country basis
We recently launched our first Diversity & Inclusion Benchmarking Survey.
Diversity & Inclusion Benchmarking Survey — ALDA has identified—through its members, DEI Task Force, and collaborative efforts—areas where there is a lack of sufficient data in our industry for our member companies to know how they are performing relative to diversity and inclusion efforts. Many are making decisions without supporting data.
As such, ALDA launched our first annual ALDA Diversity & Inclusion Benchmarking Study late last year in partnership with Pearl Meyer, the highly respected compensation consultancy. The results were shared with our members who participated in February.
This confidential and anonymous survey aimed to address this lack of data, and benchmarked industry performance related to two primary areas:
- Diversity in the workplace
- Diversity and inclusion practices
This survey received responses from 45 member companies and includes representation data on ~265,000 employees. We are very pleased with the results, particularly because this is our first time ever conducting a survey like this. There is a clear appetite for this information in our industry, and we are excited to be able to provide this actionable data set through ALDA.
We are also building out a higher-level executive summary with a corresponding narrative to share with the industry, including non-participants. We expect that to be completed shortly.
We certainly aren’t an anomaly but there is clear opportunity for growth here within most of our individual companies. We will work together to make progress and will continue to work through ALDA to drive positive change. Our member companies need this data, and so does our industry. This will help ALDA as an association track how we are doing relative to other industries, in healthcare and otherwise. This will also help us, and our member companies, make strategic decisions.
ALDA is excited to drive this initiative; we hope you agree that this data will be of high value to the association, our industry, and most importantly to you, our members.
Have questions or concerns? Or just need more information from ALDA? Contact us today.
1800 Diagonal Road
Alexandria, VA 22314